ETON
ETON
NASDAQ · Pharmaceuticals

Eton Pharmaceuticals Inc

$44.60
-1.58 (-3.42%)
As of Aug 9, 10:25 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -73.3% upside
Low Target $8.04
Average Target $11.93
High Target $13.91
Current Price $44.60
Current
$44.60
Target
$11.93
$8.04 $11.93 avg $13.91
Scenario Analysis
Bear Case
$8.04
-82.0%
Low target
Base Case
$11.93
-73.3%
Avg target
Bull Case
$13.91
+-68.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$50.18
-11.1% from high
52-Week Low
$14.27
+212.5% from low
Target vs 52W High
$11.93
-76.2% vs high
Next Earnings Report
Aug 13, 2026 · After Market Close
2d
until earnings
EPS Est: $0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%